Clinical Trial Update: To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery Disease [Phase 2]

View source ↗

Summary

This clinical trial update reports results from a Phase 2 study evaluating safety, pharmacokinetics and pharmacodynamics of MEDI6012 in subjects with stable cor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• MEDI6012

Snippet

Sponsor: MedImmune LLC | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-03-19